Bing Zhang
Statistical analyses for pharmacokinetic
Clinical sciences
Global drug develoopment experts
Ireland
Biography
Dr. Bing Zhang has fifteen years of experience in statistical analyses for pharmacokinetic (PK) and Phase I-IV clinical trials as well as integrated summaries of safety (ISS) and efficacy (ISE) for new drug applications (NDA) in various therapeutic areas such as pain control, cardiovascular, respiratory, psychotic disorders, oncology, anti-viral, blood substitute, etc.
Research Interest
Oncology,pcsychiatrics
